Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...

Novo Nordisk has sought strength in numbers in the battle for telehealth obesity drug sales in the US, enlisting the aid of ...

(Hims doesn't sell compounded tirzepatide, but recently added branded Zepbound to its offerings.) Got a Tip? Are you an employee or patient of a company that sells GLP-1 medications? We'd like to ...

Shares of Hims & Hers Health skyrocketed to 40% in the premarket following the telehealth company’s partnership announcement ...

The NBA Hall of Famer joined forces with the telehealth platform to restart his weight loss journey and raise awareness about ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg ...

Hims & Hers said it would add branded tirzepatide, the active ingredient for Mounjaro and Zepbound, to its platform. Eli Lilly said on the same day that it "has no affiliation" with Hims & Hers ...

Hims & Hers’ partnership with Novo (NVO) comes weeks after the company started to sell branded versions of Eli Lilly’s (NYSE:LLY) popular weight loss therapy tirzepatide on its platform.